VERMOX Drug Patent Profile

✉ Email this page to a colleague

When do Vermox patents expire, and what generic alternatives are available?

Vermox is a drug marketed by Janssen Pharms and is included in two NDAs.

The generic ingredient in VERMOX is mebendazole. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mebendazole profile page.

Summary for VERMOX

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	142
Clinical Trials:	6
Patent Applications:	3,606
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in VERMOX?	VERMOX excipients list
DailyMed Link:	VERMOX at DailyMed

Drug patent expirations by year for VERMOX

Recent Clinical Trials for VERMOX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
RDD Pharma Ltd	Phase 2
PATH	Phase 4
Kintampo Health Research Centre, Ghana	Phase 4

See all VERMOX clinical trials

Pharmacology for VERMOX

Drug Class	Anthelmintic

Anatomical Therapeutic Chemical (ATC) Classes for VERMOX

P02CA	Benzimidazole derivatives
P02C	ANTINEMATODAL AGENTS
P02	ANTHELMINTICS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for VERMOX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	VERMOX	mebendazole	TABLET, CHEWABLE;ORAL	017481-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Janssen Pharms	VERMOX	mebendazole	TABLET, CHEWABLE;ORAL	208398-001	Oct 19, 2016		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VERMOX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	VERMOX	mebendazole	TABLET, CHEWABLE;ORAL	017481-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VERMOX

See the table below for patents covering VERMOX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Italy	1035027	PROCEDIMENTO PER LA PREPARAZIONE DI CARBAMMATI BENZIMIDAZOLICI UTILI PER LA LORO ATTIVITA ANTI ELMINTICA E PRODOTTO RELATIVO	⤷ Try a Trial
Sweden	366045		⤷ Try a Trial
Malaysia	7300477	NOVEL ALKYL ESTERS OF N-[5(6)-ACYL-2-BENZIMIDAZOLYL]CARBAMIC ACIDS AND A PROCESS FOR THE PREPARATION THEREOF	⤷ Try a Trial
Spain	380579		⤷ Try a Trial
Israel	34746	BENZIMIDAZOLE CARBAMATES,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for VERMOX

Recent Clinical Trials for VERMOX

Pharmacology for VERMOX

Anatomical Therapeutic Chemical (ATC) Classes for VERMOX

Make Better Decisions: Try a trial or see plans & pricing